Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study.

Cancers (Basel) · 2021 · PMC8200096 · PMID 34199796

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the univariate analyses, CA19-9 ≤ 200 UI/L ( p = 0.015; OR = 4.15; 95% CI: 1.44–15.05) was associated with secondary surgery, whereas tumor size < 40 mm ( p = 0.051; OR = 2.99; 95% CI: 1.05–9.86) showed a trend towards this.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.